CFAS is one of the named cohorts which will be taking part in the Dementia’s Platform UK, which is tasked with bringing together the best scientific minds in a coordinated way to work together which will help accelerate progress in dementia research.  

Who is involved: The platform is a public-private partnership between the Medical Research Council and Industry.  Leading researchers from UK universities (Cambridge, Cardiff, Edinburgh, Imperial College, Manchester, Newcastle, Oxford, Swansea and UCL) are teaming up with drug companies (GlaxoSmithKline, Janssen Research & Development, AstraZeneca-MedImmune, Ixico, SomaLogic and Araclon) and are working together to transform the best research into the best treatments as quickly as possible.  

For further information see www.dementiasplatform.uk